Back to search

Ireland· IE-PA-PPA0465/499/001

innohep 4,500 IU, solution for injection

A tinzaparin product containing tinzaparin sodium, registered in Ireland by PCO Manufacturing Ltd.. The same ATC class is registered in 9 of our 19 countries.

ATC B01AB10

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedinnohep 4,500 IU, solution for inject…ATCB01AB10REGISTER NO.IE-PA-PPA0465/499/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Tinzaparin is registered in 9 of 19 countries.

Countries holding a registration under ATC B01AB10 (tinzaparin), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 3 of them publish a price we can compare per daily dose

Tinzaparin · ATC B01AB10

9 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Tinzaparin sodium
Manufacturer
PCO Manufacturing Ltd.
Country
Ireland (IE)
ATC code
B01AB10
ATC class
Tinzaparin
Defined daily dose
3.5 TSD, E
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PPA0465/499/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

162 interactions on record for tinzaparin.

Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tinzaparin · interactions on record

162 records

  • 94 severe
  • 68 moderate

Most severe, free to view

  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tinzaparin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tinzaparin products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Belgium · Innohep
  • Cyprus · Innohep
  • Germany · Innohep, Innohep Multi
  • Denmark · Innohep
  • Spain · Innohep
  • Finland · Innohep, Innohep®
  • France · Innohep
  • United Kingdom (Northern Ireland) · Innohep, Tinzaparin
  • Greece · Innohep
  • Italy · Innohep
  • Luxembourg · Innohep
  • Netherlands · Innohep
  • Portugal · Innohep
  • Romania · Innohep
  • Sweden · Innohep

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9d9e479-bdb1-4577-abb5-b0f9290baabf
GET /v1/drugs/d9d9e479-bdb1-4577-abb5-b0f9290baabf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "routes": [
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B01AB",
    "B01AB10"
  ],
  "strength": null,
  "pa_number": "PPA0465/499/001",
  "substances": [
    "Tinzaparin sodium"
  ],
  "legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
  "market_info": "Unknown",
  "authorised_at": "03/03/2023",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about tinzaparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.